Antiretroviral Therapy Journal Articles

• Updated Direct Costs of Medical Care for HIV From 2006-2017 How have costs for HIV care evolved and changed in recent years? A new study provides an update.
  HIV Medicine, July 31, 2020
• RBP4, a Potential Biomarker of Frailty in HIV Might higher levels of retinol-binding protein 4 predict frailty in HIV-infected patients?
  HIV Medicine, July 24, 2020
• COVID-19 and Liver Disease--What We Know This review summarizes changes in liver function observed during SARS-CoV-2 infection. What impact does COVID-19 have on patients with underlying chronic liver disease?
  Alimentary Pharmacology & Therapeutics, July 20, 2020
• Proportion and Disparities of HIV PrEP Among Key Populations A better understanding of PrEP use disparities among key populations may help identify strategies to better target these vulnerable groups.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, July 16, 2020
• Safety of In-Utero Antiretroviral Exposure How safe is the use of ART during pregnancy? Might in-utero exposure to these drugs contribute to a higher risk for neurologic abnormalities?
  AIDS, July 16, 2020
• Switching TDF to TAF in a Real Life Setting Are there benefits to an ART switch from tenofovir disoproxil fumarate to tenofovir alafenamide?
  HIV Medicine, July 10, 2020
• HCV RNA Detection Using Capillary Blood by Finger Prick How accurate is the new GenXpert instrument, which is used to diagnose HCV RNA from capillary whole blood obtained by finger prick?
  Journal of Viral Hepatitis, July 03, 2020
• ART and the Risk of Sexual Transmission of HIV Is the use of ART associated with a reduction in HIV sexual transmission risk?
  HIV Medicine, July 03, 2020
• COVID-19 Prevention, Diagnosis, Management in the IBD Patient Since many IBD therapies may weaken the immune system and increase infection risk, IBD patient management presents a challenge during the current COVID-19 pandemic.
  Alimentary Pharmacology & Therapeutics, July 01, 2020
• Switching to DRV/c in Virologically Suppressed HIV Patients What benefits might virologically suppressed HIV-positive patients obtain from switching to a darunavir/cobicistat-based ART regimen?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, July 01, 2020
• Real-World Effectiveness of Dolutegravir-Based ART Data from a large cohort study of HIV patients provides insight into the real-world effectiveness of dolutegravir-based antiretroviral therapy.
  AIDS, June 23, 2020
• HCV Resistance-associated Substitutions in Failed DAA Therapy This study aimed to quantify and characterize resistance-associated substitutions in HCV patients refractory to direct-acting antiviral treatment.
  Journal of Viral Hepatitis, June 17, 2020
• Sex Differences in Outcomes for Third-Line ART Do women presenting for third-line ART experience different outcomes than men? A new study examines the gender disparities that may exist.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, May 29, 2020
• PrEP Use Among Male Sex Partners of HIV-Positive Men Do the male sexual partners of HIV-positive men routinely take PrEP to reduce the risk of becoming infected?
  AIDS, May 26, 2020
• Renal Injury and HIV: What Remains After 30 Years? What have we learned about the incidence of renal disease in the HIV population?
  Nephrology Dialysis Transplantation, May 22, 2020
• ART and SVR Among Active Duty Service Members With HIV This report demonstrates that service members with HIV infection who remain in care and receive timely anteretroviral therapy can achieve both early and sustained viral suppression.
  Morbidity & Mortality Weekly Report, May 15, 2020
• Long-term Safety and Efficacy of OBV/PTV/r + DSV in HCV This study reports on the long-term liver disease-associated outcomes for a DAA regimen consisting of ombitasvir/paritaprevir/ritonavir plus dasabuvir +/- ribavirin for the treatment of chronic HCV.
  Journal of Viral Hepatitis, May 14, 2020
• CVD in HIV Controller and Long-Term Nonprogressors A new study compares the prevalence of subclinical CVD between these two HIV-infected populations.
  HIV Medicine, May 13, 2020
• Chemsex Drugs on the Rise The use of sex-enhancing drugs among men who have sex with men is an increasing trend. Is this trend associated with risky sexual behavior and other recreational drug use?
  HIV Medicine, May 06, 2020
• Post-Exposure Prophylaxis After Consented Sexual Exposure How has PEP for consented sexual exposure impacted the rates of averted HIV infections?
  HIV Medicine, April 29, 2020